Clinical Trial Update: Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

This clinical trial update reports on the Phase 2 CACTUX study evaluating cisplatin, nab-paclitaxel, and cetuximab for incurable head and neck squamous cell car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING